205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-0.75%
Both yoy net incomes decline, with AVGO at -5.11%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
6.67%
Some D&A expansion while AVGO is negative at -0.75%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
-90.38%
Negative yoy deferred tax while AVGO stands at 20.57%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
-28.83%
Negative yoy SBC while AVGO is 22.61%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
98.82%
Well above AVGO's 143.20% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
74.68%
AR growth while AVGO is negative at -27.03%. John Neff would note competitor possibly improving working capital while we allow AR to rise.
59.41%
Inventory shrinking or stable vs. AVGO's 238.46%, indicating lean supply management. David Dodd would confirm no demand shortfall.
-63.51%
Negative yoy AP while AVGO is 264.91%. Joel Greenblatt would see quicker payments or less reliance on trade credit than competitor, unless expansions are hindered.
359.38%
Some yoy usage while AVGO is negative at -16.21%. John Neff would see competitor possibly generating more free cash from minor accounts than we do.
61.63%
Some yoy increase while AVGO is negative at -38.89%. John Neff would see competitor possibly reining in intangible charges or revaluations more effectively than we do.
38.46%
Operating cash flow growth above 1.5x AVGO's 4.82%. David Dodd would confirm superior cost control or stronger revenue-to-cash conversion.
-3.39%
Negative yoy CapEx while AVGO is 0.00%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
No Data
No Data available this quarter, please select a different quarter.
23.89%
Less growth in investment purchases vs. AVGO's 53.81%, preserving near-term liquidity. David Dodd would confirm no strategic investment opportunities are lost.
-5.87%
We reduce yoy sales while AVGO is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
-111.90%
We reduce yoy other investing while AVGO is 1100.00%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
28.97%
Investing outflow well above AVGO's 54.72%. Michael Burry sees possible short-term FCF risk unless these invests pay off quickly vs. competitor’s approach.
100.00%
Debt repayment growth of 100.00% while AVGO is zero at 0.00%. Bruce Berkowitz sees a mild advantage that can reduce interest costs unless expansions demand capital here.
4.62%
We slightly raise equity while AVGO is negative at -100.00%. John Neff sees competitor possibly preserving share count or buying back shares.
41.77%
Repurchase growth 1.25-1.5x AVGO's 36.64%. Bruce Berkowitz would confirm if the firm invests enough in expansions while boosting EPS.